BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30007087)

  • 1. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
    Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
    Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
    Hammond WA; Vishnu P; Rodriguez EM; Li Z; Dholaria B; Shreders AJ; Rivera CE
    Mayo Clin Proc; 2019 Nov; 94(11):2199-2208. PubMed ID: 31685150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
    Depré F; Aboud N; Mayer B; Salama A
    PLoS One; 2018; 13(6):e0198184. PubMed ID: 29856800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
    Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O
    Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014.
    Weide R; Feiten S; Friesenhahn V; Heymanns J; Kleboth K; Thomalla J; van Roye C; Köppler H
    Oncol Res Treat; 2016; 39(1-2):41-4. PubMed ID: 26891217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reemergence of Splenectomy for ITP Second-line Treatment?
    Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
    Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.
    Al Askar AS; Shaheen NA; Al Zahrani M; Al Otaibi MG; Al Qahtani BS; Ahmed F; Al Zughaibi M; Kamran I; Mendoza MA; Khan A
    Int J Hematol; 2018 Jan; 107(1):69-74. PubMed ID: 28895035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia.
    Togasaki E; Shimizu N; Nagao Y; Kawajiri-Manako C; Shimizu R; Oshima-Hasegawa N; Muto T; Tsukamoto S; Mitsukawa S; Takeda Y; Mimura N; Ohwada C; Takeuchi M; Sakaida E; Iseki T; Yoshitomi H; Ohtsuka M; Miyazaki M; Nakaseko C
    Ann Hematol; 2018 Apr; 97(4):655-662. PubMed ID: 29332223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Azathioprine as a Second Line Therapy for Primary Immune Thrombocytopenic Purpura.
    Poudyal BS; Sapkota B; Shrestha GS; Thapalia S; Gyawali B; Tuladhar S
    JNMA J Nepal Med Assoc; 2016; 55(203):16-21. PubMed ID: 27935917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A
    Platelets; 2011; 22(1):1-7. PubMed ID: 20964585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of vincristine in splenectomized patients with refractory or relapsed immune thrombocytopenia: a retrospective single-center study.
    Park YH; Yi HG; Lee MH; Kim CS; Lim JH
    Int J Hematol; 2016 Feb; 103(2):180-8. PubMed ID: 26588926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study.
    Tjønnfjord E; Holme PA; Darne B; Khelif A; Waage A; Michel M; Ben Romdhan N; Ghanima W
    Br J Haematol; 2020 Nov; 191(3):460-465. PubMed ID: 32342497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.
    Rossi G; Cattaneo C; Motta M; Pizzocaro C; Lanzi S; Pouchè A
    Hematol J; 2002; 3(3):148-52. PubMed ID: 12111651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
    Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
    Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
    Colović M; Suvajdzic N; Colović N; Tomin D; Vidović A; Palibrk V
    Platelets; 2011; 22(2):153-6. PubMed ID: 21142405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.